Leap Therapeutics Inc. (LPTX) is priced at $1.50 after the most recent trading session. At the very opening of the session, the stock price was $1.54 and reached a high price of $1.56, prior to closing the session it reached the value of $1.54. The stock touched a low price of $1.48.
Recently in News on November 12, 2020, Leap Therapeutics Reports Third Quarter 2020 Financial Results. Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended September 30, 2020. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Leap Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.1800 on 02/19/20, with the lowest value was $1.0200 for the same time period, recorded on 01/02/20.
Leap Therapeutics Inc. (LPTX) full year performance was 96.98%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Leap Therapeutics Inc. shares are logging -52.83% during the 52-week period from high price, and 134.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.64 and $3.18.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1075292 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Leap Therapeutics Inc. (LPTX) recorded performance in the market was 33.93%, having the revenues showcasing -19.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 86.16M, as it employees total of 24 workers.
The Analysts eye on Leap Therapeutics Inc. (LPTX)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.9365, with a change in the price was noted -0.6800. In a similar fashion, Leap Therapeutics Inc. posted a movement of -31.19% for the period of last 100 days, recording 709,867 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for LPTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Leap Therapeutics Inc. (LPTX)
Raw Stochastic average of Leap Therapeutics Inc. in the period of last 50 days is set at 3.26%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 3.70%. In the last 20 days, the company’s Stochastic %K was 7.54% and its Stochastic %D was recorded 9.74%.
Considering, the past performance of Leap Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 33.93%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -30.23%, alongside a boost of 96.98% for the period of the last 12 months. The shares increased approximately by -5.66% in the 7-day charts and went up by -30.23% in the period of the last 30 days. Common stock shares were lifted by -19.79% during last recorded quarter.